Literature DB >> 25892636

Towards a full integration of optimization and validation phases: An analytical-quality-by-design approach.

C Hubert1, S Houari2, E Rozet2, P Lebrun2, Ph Hubert2.   

Abstract

When using an analytical method, defining an analytical target profile (ATP) focused on quantitative performance represents a key input, and this will drive the method development process. In this context, two case studies were selected in order to demonstrate the potential of a quality-by-design (QbD) strategy when applied to two specific phases of the method lifecycle: the pre-validation study and the validation step. The first case study focused on the improvement of a liquid chromatography (LC) coupled to mass spectrometry (MS) stability-indicating method by the means of the QbD concept. The design of experiments (DoE) conducted during the optimization step (i.e. determination of the qualitative design space (DS)) was performed a posteriori. Additional experiments were performed in order to simultaneously conduct the pre-validation study to assist in defining the DoE to be conducted during the formal validation step. This predicted protocol was compared to the one used during the formal validation. A second case study based on the LC/MS-MS determination of glucosamine and galactosamine in human plasma was considered in order to illustrate an innovative strategy allowing the QbD methodology to be incorporated during the validation phase. An operational space, defined by the qualitative DS, was considered during the validation process rather than a specific set of working conditions as conventionally performed. Results of all the validation parameters conventionally studied were compared to those obtained with this innovative approach for glucosamine and galactosamine. Using this strategy, qualitative and quantitative information were obtained. Consequently, an analyst using this approach would be able to select with great confidence several working conditions within the operational space rather than a given condition for the routine use of the method. This innovative strategy combines both a learning process and a thorough assessment of the risk involved.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Method lifecycle; Quality-by-design; Quantitative design space; Risk management; Validation

Mesh:

Substances:

Year:  2015        PMID: 25892636     DOI: 10.1016/j.chroma.2015.03.059

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  4 in total

Review 1.  Analytical Method Lifecycle Management in Pharmaceutical Industry: a Review.

Authors:  Lúcia Volta E Sousa; Ricardo Gonçalves; José C Menezes; António Ramos
Journal:  AAPS PharmSciTech       Date:  2021-04-09       Impact factor: 3.246

2.  Quality by design approach for green HPLC method development for simultaneous analysis of two thalassemia drugs in biological fluid with pharmacokinetic study.

Authors:  Michel Y Fares; Maha A Hegazy; Ghada M El-Sayed; Maha M Abdelrahman; Nada S Abdelwahab
Journal:  RSC Adv       Date:  2022-05-09       Impact factor: 4.036

Review 3.  Optimizing Mass Spectrometry Analyses: A Tailored Review on the Utility of Design of Experiments.

Authors:  Elizabeth S Hecht; Ann L Oberg; David C Muddiman
Journal:  J Am Soc Mass Spectrom       Date:  2016-03-07       Impact factor: 3.109

Review 4.  Quality Control and Downstream Processing of Therapeutic Enzymes.

Authors:  David Gervais
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.